Expert Opinion on Biological Therapy
Volume 21, 2021 - Issue 12
Original Research
Is there still a role for talimogene laherparepvec (T-VEC) in advanced melanoma? An indirect efficacy comparison of T-VEC plus ipilimumab combination therapy versus T-VEC alone as salvage therapy in unresectable metastatic melanoma
, , 
, &
Ahmad Alamerc Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA;d Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabiahttps://orcid.org/0000-0002-2091-1376View further author information
https://orcid.org/0000-0002-2091-1376View further author information, & Ivo Abrahamb Department of Clinical Translational Sciences, College of Medicine, University of Arizona, Tucson, AZ, USA;c Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA;e Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ, USA;f University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USAhttps://orcid.org/0000-0003-0490-4421View further author information
https://orcid.org/0000-0003-0490-4421View further author information